Testing effectiveness (Phase 2)Study completedNCT01967537
What this trial is testing
Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine Tumors
Who this might be right for
Neuroendocrine TumorsVon Hippel-Lindau SyndromeHippel-Lindau Disease
National Cancer Institute (NCI) 341